Buti, Sebastiano <br/><br/>
Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  06 2017 
 - 1858-1859 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2016.71.6506  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides<br/>Carcinoma, Renal Cell<br/>Humans<br/>Kidney Neoplasms<br/>Pyridines<br/>Sunitinib